ClassID:

94735

C07D273/06 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups  -  having two nitrogen atoms and only one oxygen atom Seven-membered rings

Recent Application in this class:
#1
20250313540
2025-10-09

PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES

#2
20250171409
2025-05-29

PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES

#3
20230089459
2023-03-23

Chemical compounds targeting the eye and use thereof in the treatment of eye diseases

#4
20190337909
2019-11-07

Creatine prodrugs, compositions and methods of use thereof

#5
20170342039
2017-11-30

Creatine prodrugs, compositions and methods of use thereof

#6
20160176829
2016-06-23

Creatine prodrugs, compositions and methods of use thereof

#7
20130064766
2013-03-14

Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof

#8
20120208997
2012-08-16

Compound having heterocyclic ring

#9
20110207925
2011-08-25

PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES

#10
20100291199
2010-11-18

Compositions and Methods For The Treatment and Prevention of Disease

#11
20090299059
2009-12-03

Compound having heterocyclic ring

#12
20090264467
2009-10-22

Agents and crystals for improving excretory potency of urinary bladder

#13
20090124800
2009-05-14

PROCESS FOR THE PREPARATION OF [1,4,5]-OXADIAZEPINE DERIVATIVES

#14
20080033167
2008-02-07

Compositions and methods for synthesizing heterocyclic therapeutic compounds

#15
20080031951
2008-02-07

Compositions and methods for the inhibition of phospholipase A2

#16
20070293469
2007-12-20

Compositions and methods for the treatment and prevention of disease

#17
20060281725
2006-12-14

Agents and crystals for improving excretory potency of urinary bladder

#18
20050159313
2005-07-21

Process for the preparation of [1,4,5]-oxadiazepine derivatives

#19
20050080265
2005-04-14

Treatment of CNS disorders using CNS target modulators

#20
20050043396
2005-02-24

5-Benzoylamino-1,3-dioxacyclanes, the method for preparing the same and their use as PKC inhibitor